Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001833141-24-000017
Filing Date
2024-09-20
Accepted
2024-09-19 17:50:55
Documents
9
Period of Report
2024-09-19

Document Format Files

Seq Description Document Type Size
1 6-K cybininc-form6xkseptember1.htm 6-K 13934
2 EX-99.1 materialchangereport-conso.htm EX-99.1 13923
3 EX-99.2 cybinshareconsolidationpre.htm EX-99.2 15207
4 EX-99.3 certificateandarticlesof.htm EX-99.3 4788
5 EX-99.4 cybinincletteroftransmittal.htm EX-99.4 26999
6 GRAPHIC certificateandarticlesof001.jpg GRAPHIC 111435
7 GRAPHIC certificateandarticlesof002.jpg GRAPHIC 103316
8 GRAPHIC certificateandarticlesof003.jpg GRAPHIC 80989
9 GRAPHIC image_0.jpg GRAPHIC 14343
  Complete submission text file 0001833141-24-000017.txt   503470
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40673 | Film No.: 241311366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)